Presepsin (soluble CD14 subtype) as a new sepsis marker: first results of the diagnostic and prognostic validity

被引：0
|
作者：
Spanuth, E. [1 ]
Ebelt, H. [2 ]
Ivandic, B. [1 ,3 ]
Werdan, K. [2 ]
机构：
[1] DIAneering Diagnost Engn & Res GmbH, Heidelberg, Germany
[2] Univ Halle Wittenberg, Univ Clin Halle Saale, Dept Med 3, D-4010 Halle, Germany
[3] Univ Heidelberg, Dept Med 3, Heidelberg, Germany
来源：
INFECTION | 2011年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [21] USEFULNESS OF PRESEPSIN (SOLUBLE CD14-ST) AS A AN EARLY DIAGNOSTIC MARKER OF SEPSIS IN LEUKEMIA
    Elsawy, M.
    HAEMATOLOGICA, 2014, 99 : 462 - 462
  • [22] Fast detection of sepsis by new biomaker, soluble CD14 subtype.
    Shirakawa, Kamon
    Naitou, Katsuki
    Takeuchi, Takashi
    Nakamura, Masaki
    Satou, Nobuhiro
    Endo, Shigeatsu
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A103 - A103
  • [23] Evaluation of a soluble CD14 subtype in patients with surgical sepsis
    Y Fukui
    Critical Care, 16 (Suppl 3):
  • [24] PLASMA LEVELS OF PRESEPSIN (SOLUBLE CD14-SUBTYPE) AS A NOVEL PROGNOSTIC MARKER FOR HEMOPHAGOCYTIC SYNDROME
    Nanno, S.
    Koh, H.
    Katayama, T.
    Hashiba, M.
    Sato, A.
    Makuuchi, Y.
    Nagasaki, J.
    Yoshimura, T.
    Okamura, H.
    Nishimoto, M.
    Hirose, A.
    Nakamae, M.
    Nakane, T.
    Hino, M.
    Nakamae, H.
    HAEMATOLOGICA, 2015, 100 : 557 - 557
  • [25] Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial
    Masson, Serge
    Caironi, Pietro
    Spanuth, Eberhard
    Thomae, Ralf
    Panigada, Mauro
    Sangiorgi, Gabriela
    Fumagalli, Roberto
    Mauri, Tommaso
    Isgro, Stefano
    Fanizza, Caterina
    Romero, Marilena
    Tognoni, Gianni
    Latini, Roberto
    Gattinoni, Luciano
    CRITICAL CARE, 2014, 18 (01)
  • [26] Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial
    Serge Masson
    Pietro Caironi
    Eberhard Spanuth
    Ralf Thomae
    Mauro Panigada
    Gabriela Sangiorgi
    Roberto Fumagalli
    Tommaso Mauri
    Stefano Isgrò
    Caterina Fanizza
    Marilena Romero
    Gianni Tognoni
    Roberto Latini
    Luciano Gattinoni
    Critical Care, 18
  • [27] Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS
    Mussap, Michele
    Puxeddu, Elisabetta
    Puddu, Melania
    Ottonello, Giovanni
    Coghe, Ferdinando
    Comite, Paola
    Cibecchini, Francesco
    Fanos, Vassilios
    CLINICA CHIMICA ACTA, 2015, 451 : 65 - 70
  • [28] SOLUBLE CD14 SUBTYPE (SCD14-ST) PRESEPSIN LEVELS IN PRETERM NEWBORNS WITH RDS
    Ergor, S.
    Koroglu, O. Altun
    Yalaz, M.
    Akisu, M.
    Kultursay, N.
    EUROPEAN JOURNAL OF PEDIATRICS, 2016, 175 (11) : 1567 - 1567
  • [29] Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis
    Burgmann, H
    Winkler, S
    Locker, GJ
    Presterl, E
    Laczika, K
    Staudinger, T
    Knapp, S
    Thalhammer, F
    Wenisch, C
    ZedwitzLiebenstein, K
    Frass, M
    Graninger, W
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (03): : 307 - 310
  • [30] Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial
    Masson, Serge
    Caironi, Pietro
    Fanizza, Caterina
    Thomae, Ralf
    Bernasconi, Roberto
    Noto, Andrea
    Oggioni, Roberto
    Pasetti, Giovanni Stefano
    Romero, Marilena
    Tognoni, Gianni
    Latini, Roberto
    Gattinoni, Luciano
    INTENSIVE CARE MEDICINE, 2015, 41 (01) : 12 - 20
12345